Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus
(NASDAQ: IONS) Delayed: 75.99 +0.10 (0.13%)
Previous Close $75.89    52 Week High $62.68 
Open $75.89    52 Week Low $19.59 
Day High $77.31    P/E N/A 
Day Low $75.77    EPS $0.00 
Volume 1,405,390